Komen Continues Grant Funding To Tissue Bank At Indiana University Simon Cancer Center

Main Category: Cancer / Oncology
Article Date: 15 May 2009 - 2:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Researchers with the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center will continue their unique work thanks to a second $1 million grant from the Komen organization.

Susan G. Komen for the Cure awarded this grant, enabling researchers to continue to collect and share healthy breast tissue samples with researchers worldwide to better understand how breast cells turn cancerous. Komen for the Cure provided an initial $1 million research grant to help start the tissue bank about one year ago.

The tissue bank -- the nation's first and only healthy breast tissue bank - currently has tissue from more than 450 women and blood samples from more than 4,500.

"We are the only repository for this much normal tissue in the world," said Anna Maria Storniolo, M.D., co-principal investigator of the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center. "There's no question that is a unique and incredibly precious resource."

Researchers from the Dana-Farber Cancer Institute and Walter Reed Medical Army Institute already are using specimens from the bank.

"In breast cancer, in order to figure out what is abnormal, you have to be able to compare it to normal. Because of that, the normal controls from the Komen Tissue Bank are incredibly important," Storniolo said.

"Research studies help us do more than develop new treatments. They also advance our understanding of how breast cancer develops in the first place, which can lead to new ways to detect or prevent the disease. This tissue bank is a unique opportunity for women to participate in and contribute to the research process," said Diana Rowden, vice president of Health Sciences for Komen for the Cure.

By collecting blood and tissue from women with and without breast cancer, researchers will be able to determine the differences between these populations, which could lead to a better understanding of the disease. Blood and tissue samples taken from women without the disease are especially helpful because there are few collections of so-called "normal" specimens.

In order to identify the changes cells undergo as they transition from normal to malignant, and to detect the earliest indication of malignant transformation, it's vital to obtain and study "true normal" breast cells.

Source
Indiana University Simon Cancer Center